Miook Cho

Miook Cho is a senior scientist at Dewpoint Therapeutics. Miook has previously worked as a principal scientist at Cygnal Therapeutics, a senior scientist at Merck, and a postdoctoral fellow at Harvard Stem Cell and Regenerative Biology and the Albert Einstein College of Medicine.

Cho's research focuses on oncology target validation by mechanistic investigation and platform development. Miook is also experienced in identifying and functionally validating novel targets anchored to human genetics in the areas of CMD (Cardio Metabolic Disease) by developing disease-relevant in vitro assays and by identifying mechanisms of the targets.

Cho received their PhD in cell and developmental biology from the Albert Einstein College of Medicine in 2012.

Dr. Miook Cho earned their Ph.D. in Human Genetics of Aging from Albert Einstein College of Medicine. Miook also holds a certification in Managing Your Time from LinkedIn.

Their manager is Isaac Klein, Chief Scientific Officer. Miook Cho works with Edgar Boczek - Senior Scientist, Xiao Tong - Head of Virology, and Thomas Jahn - Head of Cardiopulmonary Biology.